Tanker Investments Ltd
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $301.9
- Today's High:
- $301.9
- Open Price:
- $301.9
- 52W Low:
- $0.41
- 52W High:
- $6
- Prev. Close:
- $308.05
- Volume:
- 10514
Company Statistics
- Market Cap.:
- $59.32 million
- Book Value:
- 2.28
- Revenue TTM:
- $0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- $138000
- Profit Margin:
- 0%
- Return on Assets TTM:
- -18.81%
- Return on Equity TTM:
- -49.23%
Company Profile
Tanker Investments Ltd had its IPO on 2021-03-19 under the ticker symbol TIL.
The company operates in the Healthcare sector and Biotechnology industry. Tanker Investments Ltd has a staff strength of 192 employees.
Stock update
Shares of Tanker Investments Ltd opened at $301.9 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of $301.9 - $301.9, and closed at $301.9.
This is a -2% slip from the previous day's closing price.
A total volume of 10,514 shares were traded at the close of the day’s session.
In the last one week, shares of Tanker Investments Ltd have increased by +8.15%.
Tanker Investments Ltd's Key Ratios
Tanker Investments Ltd has a market cap of $59.32 million, indicating a price to book ratio of 0.3027 and a price to sales ratio of 55329.793.
In the last 12-months Tanker Investments Ltd’s revenue was $0 with a gross profit of $138000 and an EBITDA of $-140224000. The EBITDA ratio measures Tanker Investments Ltd's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Tanker Investments Ltd’s operating margin was 0% while its return on assets stood at -18.81% with a return of equity of -49.23%.
In Q2, Tanker Investments Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Tanker Investments Ltd’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-1.45 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Tanker Investments Ltd’s profitability.
Tanker Investments Ltd stock is trading at a EV to sales ratio of 43213.9502 and a EV to EBITDA ratio of 0.4961. Its price to sales ratio in the trailing 12-months stood at 55329.793.
Tanker Investments Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $408.31 million
- Total Liabilities
- $18.38 million
- Operating Cash Flow
- $10.33 million
- Capital Expenditure
- $6.98 million
- Dividend Payout Ratio
- 0%
Tanker Investments Ltd ended 2024 with $408.31 million in total assets and $0 in total liabilities. Its intangible assets were valued at $408.31 million while shareholder equity stood at $296.52 million.
Tanker Investments Ltd ended 2024 with $0 in deferred long-term liabilities, $18.38 million in other current liabilities, in common stock, $-500624000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $21.76 million and cash and short-term investments were $202.86 million. The company’s total short-term debt was $1,884,000 while long-term debt stood at $81.52 million.
Tanker Investments Ltd’s total current assets stands at $220.59 million while long-term investments were $0 and short-term investments were $179.94 million. Its net receivables were $0 compared to accounts payable of $2.16 million and inventory worth $0.
In 2024, Tanker Investments Ltd's operating cash flow was $10.33 million while its capital expenditure stood at $6.98 million.
Comparatively, Tanker Investments Ltd paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $301.9
- 52-Week High
- $6
- 52-Week Low
- $0.41
- Analyst Target Price
- $4
Tanker Investments Ltd stock is currently trading at $301.9 per share. It touched a 52-week high of $6 and a 52-week low of $6. Analysts tracking the stock have a 12-month average target price of $4.
Its 50-day moving average was $236.84 and 200-day moving average was $169.61 The short ratio stood at 3.6 indicating a short percent outstanding of 0%.
Around 684.2% of the company’s stock are held by insiders while 7152.5% are held by institutions.
Frequently Asked Questions About Tanker Investments Ltd
Similar Industry Stocks (Biotechnology)
Most Active
Top Gainers
Top Losers
About
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its lead product is ITIL-306, a Co-Stimulatory Antigen Receptor molecule to recognize folate receptor alpha, a tumor-associated antigen that is expressed on various solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer. The company was incorporated in 2018 and is headquartered in Dallas, Texas.